BackHome

  • A
  • A
  • A
  • (resize font)

LSVT® Global Receives European Union CE registration

LSVT Global, Inc. is proud to announce the CE registration of the LSVT Companion™ treatment system for speech disorders associated with Parkinson’s Disease and other neurological disorders.

(NYC, New York) LSVT Global, Inc. is proud to announce the CE registration of the LSVT Companion™ treatment system for speech disorders associated with Parkinson’s Disease and other neurological disorders. This allows availability in the European Union of the eagerly awaited Companion Clinician and Home editions to LSVT LOUD certified clinicians and their clients. Both versions of this highly acclaimed treatment system can now be purchased online in the United Kingdom. French and German documentation is in preparation with expected availability in French and German speaking EU countries early this year. This CE registration follows earlier FDA clearance of the Companion.

Developed with funding assistance from NIH and the Michael J. Fox Foundation, the LSVT Companion is a software aid to clinicians providing LSVT LOUD treatments. The Home edition allows clients to practice the treatment independently while being monitored by their clinician. LSVT LOUD™ speech treatment is the only protocol to be clinically proven to improve communication in people with Parkinson’s Disease and other neurological movement disorders. Over 6,000 speech-language pathologists worldwide have been trained and certified by LSVT Global to provide this treatment.

Through the LSVT Companion, clients interact with dynamic software as they move through the well established and highly efficacious LSVT LOUD treatment. The Companion guides and tracks a client’s speech performance and allows for direct long-term client use outside of the clinical setting, significantly expanding clinician impact and reducing time and cost.

About LSVT Global: LSVT Global provides innovative speech and whole body treatments to improve the quality of life of adults and children with neurological disorders, such as Parkinson disease, multiple sclerosis, stroke and cerebral palsy by enabling them to communicate and move more effectively. LSVT Global’s business is founded on two main pillars. The company offers clinical training to health care practitioners around the world and delivers treatments via Telemedicine and other technological applications.

For additional information and to purchase the LSVT Companion click here.

For business development and investor relations please contact: info@lsvtglobal.com 
 



Latest News

LSVT Global Kicks Off Our 2017 Small Student Grant Competition!

October 21, 2016 2:12 pm MST

LSVT Global is pleased to provide seed funding to speech, physical and occupational therapy graduate students (including post-doctoral trainees) planning on or completing behavioral treatment studies with neurologically impaired patients. The behavioral treatment does NOT need to be LSVT BIG or LSVT LOUD. Domestic (USA) and international applications are welcome. More Info